Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
The weight loss drug space will be dominated by three big pharma players, two of which are way ahead of the game. → Read More
The regulator said its decision "sends a clear signal to the market" about consolidation in the pharmaceutical market, though analysts expect the deal will still go through despite delays. → Read More
Eli Lilly stock is up on news that its new Alzheimer's drug showed reduction in cognitive decline. → Read More
Walgreens faces backlash over misperception of its intent to sell abortion pill in some states. → Read More
Novavax warns of uncertain 2023 outlook as COVID-19 market turns commercial and new CEO calls for pipeline assessment. → Read More
Seagen is once again an acquisition target this year, pursued by yet another partner, Pfizer. Last year, a deal with Merck fell through over price disagreements. → Read More
CVS is becoming a dominant player beyond pharmacies. It's planned acquisition of Oak Street Health furthers that view. → Read More
Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies. → Read More
Amazon announces a new drug pass for Prime members. → Read More
Carbon Health had to slow its growth in response to a cooler market for health care investment this year. → Read More
Novavax (NVAX) is readying its forces to be a fully commercially-licensed company by the end of 2023, with a strong balance sheet and the workforce to achieve the endpoint. → Read More
Moderna will set the price of its COVID-19 vaccine at the same level as Pfizer when the shots hit the commercial market this year. → Read More
Walgreens is competing with CVS and Walmart to enter the clinical trial space at a time when attention on the industry has spiked amid concerns of a lack of diversity of trial participants. → Read More
Since the start of the pandemic, the pharmaceutical industry's reliance on overseas manufacturing has been in the spotlight. → Read More
Children's fever and pain reductio medications are in short supply, forcing major retail pharmacies to limit purchases. → Read More
Moderna and Merck released preliminary results of a personalized cancer vaccine for late-stage melanoma patients. → Read More
Cloud computing is not a new frontier in health care, but it is finally starting to bear some fruit, AWS exec Dr. Taha Kass-Hout, told Yahoo Finance. → Read More
Hundreds of Americans die each day from COVID — and the unvaccinated make up a majority of those dead and hospitalized. → Read More
Uber Health expanding access to rides for patients in employer-sponsored plan market. → Read More
Walgreens' (WBA) new president of U.S. health care is still familiarizing himself with the company's vast portfolio of businesses, but he's clear about one... → Read More